Delivery Order SPE2DB24D1034-SPE2DB25FWAM7

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,022.80, is a Firm Fixed Price Delivery Order for the procurement of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. This award is not associated with a set-aside program, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.08 delivery order contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 31, 2024 and is a firm fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,108.08 Firm Fixed Price Delivery Order covers the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and was awarded on December 2, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.60 firm-fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription drug. The contract has an ultimate completion date of March 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,799.93, is a delivery order for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to manage diabetes. The contract has an ultimate completion date of November 14, 2023 and is a firm fixed-price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,355.21 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is a Delivery Order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,087.68 Firm Fixed Price contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 29, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML medical supplies. The contract, valued at $1,298.58, is a Firm Fixed Price Delivery Order with a completion date of January 17, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,848.13 Firm Fixed Price delivery order contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialized insulin medication used to treat diabetes. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 30, 2025. This delivery order is part of a larger...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAM7
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.94, is a Firm Fixed Price Delivery Order for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:05 PM